Please wait while we open this resource.
K
Clinical reviews
TYPE 1 DIABETES
Laura M. Jacobsen, MD; Desmond A. Schatz, MD
PDF14 pages1.3 MB
Type 1 diabetes is characterized by hyperglycemia resulting from the autoimmune destruction of insulin-producing beta cells in the pancreas. It accounts for a significant portion of diabetes cases globally and is associated with various complications, including microvascular and macrovascular diseases. The review discusses the presence of autoantibodies at diagnosis, the typical age of onset, and the necessity for lifelong insulin therapy, including modern management techniques such as continuous glucose monitoring and insulin pumps.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology